Summary
Introduction
Ultrasound (US) preoperative examination of the axillary lymph nodes combined with the fine needle aspiration biopsy (FNAB) is often used in order to reduce the number of sentinel lymph node (SLN) biopsy procedures in clinically node negative breast cancer patients. The pathohistological characteristics of the ultrasonically negative axillary lymph nodes in clinically negative axillary lymph nodes are not known. The aim of our study was to compare the pathohistological characteristics of ultrasonically uninvolved axillary lymph nodes (US group) versus clinically uninvolved axillary lymph nodes (non-US group) in SLN biopsy candidates.
Methods
We included 658 patients after SLN biopsy; 286 patients in the US group and 372 in the non-US group. The pathohistological characteristics of axillary lymph nodes were evaluated by univariate analysis and logistic regression.
Results
In the univariate analysis, the proportion of macrometastastic SLN, total number of metastatic lymph nodes per patient, proportion of nonsentinel lymph node (NSLN) metastases and proportion of NSLN macrometastases were found to be lower in the US group compared to the non-US group. In the logistic regression model, only US of the axilla (p=0.010; OR: 0.57) and tumor size were significant predictors for the presence of SLN macrometastases or macrometastatic NSLN (p<0.001; OR: 0.23).
Conclusion
The patients with US negative axillary lymph nodes form a distinct subgroup of early breast cancer patients having a significantly lower tumor burden in the axillary lymph nodes compared to those with only clinically negative axillary lymph nodes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schwartz GF, Giuliano AE, Veronesi U,: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, PennsylvaniaCancer 94: 2542–2551, 2002
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R,: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerN Engl J Med 349: 546–553, 2003
Torrenga H, Fabry H, van dS Jr., van Diest PJ, Pijpers R, Meijer S,: Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysisJ Surg Oncol 88: 4–7, 2004
Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS, III,: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 proceduresAnn Surg 240: 462–468, 2004
Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA,: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsCancer 98: 2307–2315, 2003
Sato K, Tamaki K, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H,: Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsyAm J Surg 187: 679–683, 2004
Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N,: Axillary lymph node staging in breast cancer by 2–fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative managementJ Natl Cancer Inst 93: 630–635, 2001
Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR,: A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancerAnn Surg Oncol 11: 846–853, 2004
Bonnema J, van Geel AN, van Ooijen B, Mali SP, Tjiam SL, Henzen-Logmans SC, Schmitz PI, Wiggers T,: Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic methodWorld J Surg 21: 270–274, 1997
de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AM, Wiggers T,: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancerBr J Surg 86: 1459–1462, 1999
Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes OR, Schultze Kool LJ,: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerEur J Cancer 39: 1068–1073, 2003
Podkrajsek M, Music MM, Kadivec M, Zgajnar J, Besic N, Pogacnik A, Hocevar M,: Role of ultrasound in the preoperative staging of patients with breast cancerEur Radiol 15: 1044–1050, 2005
Zgajnar J, Frkovic-Grazio S, Besic N, Hocevar M, Vidergar-Kralj B, Gerljevic A, Pogacnik A,: Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients–results of a large seriesJ Surg Oncol 85: 82–86, 2004
Sobin LHWC. 2002. UICC TNM Classification of Malignant tumours, 6th edition. New York: John Wiley and Sons
Davies GC, Millis RR, Hayward JL,: Assessment of axillary lymph node status. Ann Surg 192: 148–151, 1980
Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer 52: 1551–1557, 1983
Cutler SJ, Axtell LM, Schottenfeld D, Farrow JH,: Clinical assessment of lymph nodes in carcinoma of the breastSurg Gynecol Obstet 131: 41–52, 1970
Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M,: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breastSurg Gynecol Obstet 152: 765–772, 1981
Specht MC, Fey JV, Borgen PI, Cody HS, III,: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?J Am Coll Surg 200: 10–14, 2005
Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, III, Kattan MW,: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsyAnn Surg Oncol 10: 1140–1151, 2003
Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE,: Predictors of non-sentinel lymph node metastasis in breast cancer patientsEur J Cancer 40: 1731–1737, 2004
Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, Zurrida S, Maisonneuve P, Paganelli G, Mazzarol G,: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsyAnn Surg 241: 319–325, 2005
Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE,: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph nodeCancer 89: 574–581, 2000
Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, Carson WB, Burak WE, Jr: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182: 316–320, 2001
Fisher ER, Anderson S, Redmond C, Fisher B,: Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminantsCancer 71: 2507–2514, 1993
Morrow M: A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol 6: 17–18, 1999
den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH, Menke-Pluymers M,: Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearanceJ Clin Pathol 55: 932–935, 2002
Nos C, Harding-MacKean C, Freneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB,: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastasesBr J Surg 90: 1354–1360, 2003
Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA,: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelinesEur J Cancer 39: 1654–1667, 2003
Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Harrison R,: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical TrialAnn Surg Oncol 7: 87–97, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zgajnar, J., Hocevar, M., Podkrajsek, M. et al. Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 97, 293–299 (2006). https://doi.org/10.1007/s10549-005-9123-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9123-6